Archives of Digestive Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518081136

Mini Review - Archives of Digestive Disorders (2023) Volume 5, Issue 3

Intestinal permeability and its association with digestive disorders: a comprehensive analysis.

Jan Bauer *

Department of Chronic Diseases, Translational Research Center for Gastrointestinal Disorders, Metabolism and Ageing, Catholic University Leuven, Leuven, Belgium

*Corresponding Author:
Jan Bauer
Department of Chronic Diseases, Translational Research Center for Gastrointestinal Disorders, Metabolism and Ageing, Catholic University Leuven, Leuven, Belgium

Received:18-April-2023, Manuscript No. AAADD-23-100540; Editor assigned: 19-April-2023, PreQC No. AAADD-23-100540(PQ); Reviewed02-May-2023, QC No. AAADD-23-100540; Revised: 04-May-2023, Manuscript No. AAADD-23-100540(R); Published: 10-May-2023, DOI:10.35841/aaadd-5.3.146

Citation: Bauer J. Intestinal permeability and its association with digestive disorders: a comprehensive analysis. Arch Dig Disord.2023;5(3):146

Visit for more related articles at Archives of Digestive Disorders


Intestinal permeability, digestive disorders, inflammatory bowel disease, celiac disease, irritable bowel syndrome.


The gastrointestinal tract plays a crucial role in digestion and nutrient absorption, acting as a selective barrier that regulates the passage of molecules from the gut lumen into the bloodstream. Intestinal permeability refers to the ability of the intestinal epithelium to control this passage. Under normal physiological conditions, the epithelial lining of the intestines forms tight junctions, which prevent the entry of harmful substances while allowing the absorption of essential nutrients. However, disruptions in intestinal permeability can occur, leading to an increased passage of antigens, toxins, and bacteria across the intestinal barrier. Mounting evidence suggests that alterations in intestinal permeability may contribute to the development and progression of various digestive disorders. This comprehensive analysis explores the relationship between intestinal permeability and digestive disorders, shedding light on potential mechanisms and clinical implications [1].

One prominent digestive disorder linked to intestinal permeability is inflammatory bowel disease (IBD). IBD encompasses conditions such as Crohn's disease and ulcerative colitis, characterized by chronic inflammation of the gastrointestinal tract. Studies have demonstrated increased intestinal permeability in individuals with IBD, suggesting that defects in the epithelial barrier function may contribute to disease pathogenesis. The compromised barrier allows luminal contents, including bacteria and their products, to penetrate the intestinal mucosa, triggering an immune response and chronic inflammation. Understanding the intricate relationship between intestinal permeability and IBD could provide insights into novel therapeutic strategies targeting the restoration of barrier integrity [2].

Celiac disease, an autoimmune disorder triggered by gluten ingestion, is another digestive disorder associated with intestinal permeability. In individuals with celiac disease, exposure to gluten leads to the release of zonulin, a protein that modulates tight junctions' opening. This results in increased intestinal permeability and allows gluten peptides to enter the lamina propria, triggering an immune response. Ongoing inflammation damages the small intestine, leading to malabsorption and various gastrointestinal symptoms. Exploring the connection between intestinal permeability and celiac disease offers potential avenues for therapeutic interventions targeting barrier function and gluten-induced immune responses [3].

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by chronic abdominal pain, bloating, and alterations in bowel habits. Although the pathophysiology of IBS remains incompletely understood, emerging evidence suggests that increased intestinal permeability may play a role. Altered barrier function may allow luminal substances to interact with immune cells in the gut mucosa, leading to low-grade inflammation and heightened visceral sensitivity. Investigating the interplay between intestinal permeability and IBS could provide insights into the underlying mechanisms and contribute to the development of personalized treatment approaches targeting barrier dysfunction [4].

Despite the growing body of evidence suggesting an association between intestinal permeability and digestive disorders, several questions remain unanswered. Further research is needed to elucidate the specific mechanisms through which alterations in intestinal permeability contribute to disease pathogenesis. Understanding the complex interplay between genetic, environmental, and immunological factors influencing intestinal permeability is crucial. Moreover, the development of non-invasive techniques to assess and monitor intestinal permeability in clinical settings would greatly facilitate diagnostic and therapeutic interventions. [5].


In conclusion, this comprehensive analysis highlights the association between intestinal permeability and digestive disorders, such as inflammatory bowel disease, celiac disease, and irritable bowel syndrome. Altered intestinal permeability can compromise the integrity of the intestinal barrier, leading to increased passage of antigens and triggering immune responses. Investigating the mechanisms underlying these associations is essential for developing targeted interventions to restore barrier function and alleviate symptoms in individuals with digestive disorders. Future research efforts should focus on advancing our understanding of the complex interplay between intestinal permeability, genetic predisposition, environmental factors, and immune dysregulation to improve diagnostic approaches and therapeutic strategies for digestive disorders.


  1. Bischoff, S. C., Barbara, G., Buurman, W., et al. Intestinal permeability—a new target for disease prevention and therapy. >. BMC Gastroenterology, 2014;14(1), 189.
  2. Indexed at, Google Scholar, Cross Ref

  3. Camilleri Á, Madsen K, Spiller R, Van Meerveld BG, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012 (6):503-12.
  4. Indexed at, Google Scholar, Cross Ref

  5. Magalhaes JG, Tattoli I, Girardin SE. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol 2007 (Vol. 19, No. 2, pp. 106-115).
  6. Indexed at, Google Scholar, Cross Ref

  7. Parodi A, Sessarego M, Greco A, et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Off J Am College Gastroenterol | ACG. 2008 ;103(5):1257-62.
  8. Indexed at, Google Scholar, Cross Ref

  9. Beumer J, Clevers H. Regulation and plasticity of intestinal stem cells during homeostasis and regeneration. Development. 2016 Oct 15;143(20):3639-49.
  10. Indexed at, Google Scholar, Cross Ref

Get the App